Thursday, February 11, 2010 2:32:30 PM
SenoRx CEO Malchow takes indefinite medical leave of absence to deal with cancer treatment
Companies:Senorx, Inc.
On Monday February 8, 2010, 10:02 am EST
IRVINE, Calif. (AP) -- Medical device maker SenoRx Inc. said Monday that CEO Lloyd H. Malchow is taking an indefinite medical leave of absence while he receives treatment for an unspecified cancer.
President and Chief Operating Officer John T. Buhler will serve as acting CEO while Malchow is on leave. Buhler, who joined the company in May 2008, has been president and COO since October 2009.
SenoRx said Malchow will still serve as a board member and be involved in major strategic decisions during his medical leave.
The company's stock was flat at $7.32 in morning trading.
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM